Study suggests CBD and CBG could be treatment for a common chronic liver disease

HempToday reports on a promising new study from The Hebrew University of Jerusalem, suggesting that CBD and CBG could be effective treatments for a widespread chronic liver disease. The analysis from HempToday highlights how this research points to the significant therapeutic potential of hemp-derived compounds, moving beyond common perceptions. This coverage underscores HempToday's role in tracking the scientific advancements that could redefine cannabinoid-based medicine. For detailed findings and the full scope of this research, read the original article on HempToday.